BioTech Company: Validating Third-Party Lab Software with Spectra Assure

A leading biotechnology company lacked confidence in their existing testing tools for the software running on their critical lab equipment. Relying mainly on questionnaires and lackluster scanning tools, these methods fell short of providing adequate visibility and protection against risks like malware, tampering, and other embedded threats. The company needed a robust solution to secure the software on their lab equipment and ensure comprehensive risk analysis and visibility.
 
Spectra Assure® allowed the security and threat management teams to assess highly specialized laboratory software for embedded threats in minutes, without the need for source code. It also allowed them to seamlessly and securely communicate those findings back to the vendor for expedited remediation.

Automating Third-Party Software Risk Management

Prior to deploying Spectra Assure, the company’s third-party software risk management strategy relied on manual, time-consuming assessment methods like security questionnaires and a subpar binary analysis tool that did not provide critical risk insights. This process created bottlenecks for certain commercial software deployments, impacting internal end users who needed access to critical lab software. Spectra Assure provided the critical comprehensive analysis of third-party software needed by the team - deconstructing large and complex software packages in minutes without the need for source code. This saved the security team countless hours and cycles that would have been spent reviewing vendor questionnaire responses. The Spectra Assure SAFE Report aggregated the analysis into specific risk categories, providing the team with a simple way to discern whether a commercial software package is safe to deploy.